Elanco Animal Free Cash Flow Over Time
| ELAN Stock | USD 12.59 0.17 1.37% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Elanco Animal Performance and Elanco Animal Correlation. Elanco |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.41 | Revenue Per Share 9.023 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0118 |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Free Cash Flow Analysis
Compare Elanco Animal Health and related stocks such as Viatris, Catalent, and Lantheus Holdings Free Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VTRS | 51.2 M | 440.6 M | 643.7 M | 772 M | 260.4 M | 1.1 B | 1.3 B | 1.2 B | 1.1 B | 1.4 B | 550.6 M | 2.5 B | 2.5 B | 2.3 B | 2.4 B |
| CTLT | 12.4 M | (16.3 M) | 15.2 M | 55.9 M | 30.8 M | 15.7 M | 159.7 M | 198 M | 29.6 M | (25.5 M) | (253 M) | (221 M) | (322 M) | (59 M) | (56 M) |
| LNTH | 15.5 M | 15.5 M | (8.3 M) | (20.6 M) | 3.5 M | 8.6 M | 42.2 M | 37.2 M | 41.1 M | 58.3 M | 3.9 M | 41.8 M | 263.4 M | 258.7 M | 271.6 M |
| HLN | 543 M | 543 M | 543 M | 543 M | 543 M | 543 M | 543 M | 543 M | 543 M | 543 M | 1.1 B | 1.1 B | 1.7 B | 1.8 B | 1.4 B |
| PAHC | (30.5 M) | 17.2 M | (19.5 M) | (20.6 M) | 48.6 M | 866 K | 77.5 M | 51.5 M | 17.3 M | 25.3 M | 19 M | (5.4 M) | (38.5 M) | 46.4 M | 48.7 M |
| PBH | 2 M | 66.8 M | 127.3 M | 108.8 M | 150.2 M | 170.8 M | 144.8 M | 197.6 M | 178.8 M | 199.8 M | 213.4 M | 250.3 M | 221.9 M | 239.4 M | 123.8 M |
| COLL | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (18 M) | (21.9 M) | (78 M) | (68 M) | 145 M | 21.3 M | (279.8 M) | 101.6 M | 122.6 M | 274.3 M | 288 M |
| PCRX | (35 M) | (37.2 M) | (88.4 M) | (56 M) | 3.6 M | (12.3 M) | 8.7 M | (1.5 M) | 34.4 M | 60.4 M | 39.2 M | 79.9 M | 115.2 M | 139.5 M | 146.5 M |
| SIGA | (2.1 M) | 25.3 M | (20.8 M) | 57.6 M | 14.1 M | 11 M | (115.6 M) | (8.3 M) | 68.8 M | (18.2 M) | 71.5 M | 11.4 M | 41.6 M | 94.8 M | 99.5 M |
| ESPR | (9.4 M) | (9.1 M) | (10.8 M) | (18.1 M) | (32.9 M) | (38.5 M) | (47.8 M) | (131.3 M) | (148.8 M) | (71.3 M) | (98.5 M) | (263.8 M) | (174.8 M) | (135.5 M) | (128.7 M) |
| TEVA | (13.2 M) | 3.1 B | 3.5 B | 2.2 B | 4.2 B | 4.8 B | 4.3 B | 2.6 B | 1.8 B | 419 M | 638 M | 236 M | 1 B | 842 M | 1.5 B |
| ALKS | (46 M) | (19.5 M) | 104.3 M | 73.1 M | (22.5 M) | (93.2 M) | (107.5 M) | (32.1 M) | 29.9 M | (18.9 M) | 40.6 M | 72.7 M | (17.2 M) | 353.3 M | 371 M |
| ITCI | (18.9 M) | (18.9 M) | (18.9 M) | (22.6 M) | (22.8 M) | (103.1 M) | (91.3 M) | (81.2 M) | (118.6 M) | (128.7 M) | (230.3 M) | (259.9 M) | (271 M) | (124.5 M) | (130.7 M) |
| IRWD | (9.4 M) | (84.9 M) | (83.6 M) | (282.9 M) | (159.1 M) | (111 M) | (129.6 M) | (103.8 M) | (79.5 M) | 3.5 M | 167 M | 261.6 M | 273.6 M | 183.2 M | 192.3 M |
Elanco Animal Health and related stocks such as Viatris, Catalent, and Lantheus Holdings Free Cash Flow description
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.My Equities
My Current Equities and Potential Positions
| Elanco Animal Health | ELAN |
| Classification | Pharmaceutical Products |
| Location | Indiana; U.S.A |
| Exchange | New York Stock Exchange |
USD 12.59
Check out Elanco Animal Performance and Elanco Animal Correlation. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Elanco Animal technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.